Evidence map›Paper›PMID 42045558›Full record

ArticleLeukemia2026

A small proportion of CD8 T cells expand robustly when stimulated with BCMAxCD3 bispecific T-cell engagers in vitro.

Kumi Shibata, Kazuhito Tsutsumi, Hiraku Murakami, Emiko Mizuta, Shunya Ikeda, Yosuke Kogue, Mizuki Kano, Kazuhiro Sanda, Yuto Maehara, Hiroki Akamine and 18 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Kumi Shibata *Department of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.ORCID http://orcid.org/0009-0004-4034-5924
Kazuhito Tsutsumi *Department of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Hiraku Murakami *Department of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Emiko MizutaDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Shunya IkedaLaboratory of Cellular Immunotherapy, World Premier International Immunology Frontier Research Center, The University of Osaka, Osaka, Japan.
Yosuke KogueDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Mizuki KanoDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Kazuhiro SandaDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.ORCID http://orcid.org/0000-0001-8878-3713
Yuto MaeharaDepartment of Clinical Laboratory and Biomedical Sciences, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Hiroki AkamineDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.ORCID http://orcid.org/0009-0003-0630-5112
Ryuhei KawamotoDepartment of Clinical Laboratory and Biomedical Sciences, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Mayuko NoguchiDepartment of Pediatrics, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Makiko SugaDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.ORCID http://orcid.org/0009-0002-5487-1525
Shuhei KidaDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Yuta YamaguchiDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Yo MizutaniDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Hisashi KatoDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Yasutaka UedaDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.ORCID http://orcid.org/0000-0003-1562-1013
Jiro FujitaDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Shinsuke KusakabeDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Hidenori KasaharaDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Akihisa HinoDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Daisuke MotookaGenome Information Research Center, Research Institute for Microbial Diseases, The University of Osaka, Osaka, Japan.
Daisuke OkuzakiGenome Information Research Center, Research Institute for Microbial Diseases, The University of Osaka, Osaka, Japan.ORCID http://orcid.org/0000-0002-4552-783X
Tomoaki UedaDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Kentaro FukushimaDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.ORCID http://orcid.org/0000-0002-8003-2584
Michiko IchiiDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Naoki HosenDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan. hnaoki@bldon.med.osaka-u.ac.jp.ORCID http://orcid.org/0000-0001-9570-0947

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) 24K02479
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42045558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.